Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin

ISSN:
1573-4943
Keywords:
insulin analogue ; peptide synthesis ; receptor binding assay ; radioimmunoassay ; lipogenesis assay
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Notes:
Abstract As part of our aim to study the conformation of insulin in solution by time-resolved fluorescence spectroscopy, we have synthesized the analogue [19-Tryptophan-A]insulin. In this compound, the tyrosine residue at position 19 of the A-chain of insulin, one of the most strongly conserved residues in insulins from various species, is substituted with the strongly fluorescent tryptophan residue. [19-Tryptophan-A]insulin displays 4.1±1.9% of the potency of natural insulin in binding to the insulin receptor from rat liver plasma membranes, 5.0±2.3% in stimulating lipogenesis in rat adipocytes, and 75.7±4% of the potency of insulin in radioimmunoassay. In connection with our previous work, these data indicate that an aromatic side chain at position A19 of insulin seems necessary but not sufficient for high biological activity. We further conclude that in regard to the immunogenic determinants of insulin, tryptophan in position A19 is an essentially neutral substitution for tyrosine in that position, in sharp contrast to the situation with regard to biological activity.
Type of Medium:
Electronic Resource
URL:
_version_ 1798296778341089280
autor Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
autorsonst Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
book_url http://dx.doi.org/10.1007/BF01025414
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM197815375
issn 1573-4943
journal_name The protein journal
materialart 1
notes Abstract As part of our aim to study the conformation of insulin in solution by time-resolved fluorescence spectroscopy, we have synthesized the analogue [19-Tryptophan-A]insulin. In this compound, the tyrosine residue at position 19 of the A-chain of insulin, one of the most strongly conserved residues in insulins from various species, is substituted with the strongly fluorescent tryptophan residue. [19-Tryptophan-A]insulin displays 4.1±1.9% of the potency of natural insulin in binding to the insulin receptor from rat liver plasma membranes, 5.0±2.3% in stimulating lipogenesis in rat adipocytes, and 75.7±4% of the potency of insulin in radioimmunoassay. In connection with our previous work, these data indicate that an aromatic side chain at position A19 of insulin seems necessary but not sufficient for high biological activity. We further conclude that in regard to the immunogenic determinants of insulin, tryptophan in position A19 is an essentially neutral substitution for tyrosine in that position, in sharp contrast to the situation with regard to biological activity.
package_name Springer
publikationsjahr_anzeige 1988
publikationsjahr_facette 1988
publikationsjahr_intervall 8014:1985-1989
publikationsjahr_sort 1988
publisher Springer
reference 7 (1988), S. 55-65
schlagwort insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
search_space articles
shingle_author_1 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
shingle_author_2 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
shingle_author_3 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
shingle_author_4 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
shingle_catch_all_1 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
Abstract As part of our aim to study the conformation of insulin in solution by time-resolved fluorescence spectroscopy, we have synthesized the analogue [19-Tryptophan-A]insulin. In this compound, the tyrosine residue at position 19 of the A-chain of insulin, one of the most strongly conserved residues in insulins from various species, is substituted with the strongly fluorescent tryptophan residue. [19-Tryptophan-A]insulin displays 4.1±1.9% of the potency of natural insulin in binding to the insulin receptor from rat liver plasma membranes, 5.0±2.3% in stimulating lipogenesis in rat adipocytes, and 75.7±4% of the potency of insulin in radioimmunoassay. In connection with our previous work, these data indicate that an aromatic side chain at position A19 of insulin seems necessary but not sufficient for high biological activity. We further conclude that in regard to the immunogenic determinants of insulin, tryptophan in position A19 is an essentially neutral substitution for tyrosine in that position, in sharp contrast to the situation with regard to biological activity.
1573-4943
15734943
Springer
shingle_catch_all_2 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
Abstract As part of our aim to study the conformation of insulin in solution by time-resolved fluorescence spectroscopy, we have synthesized the analogue [19-Tryptophan-A]insulin. In this compound, the tyrosine residue at position 19 of the A-chain of insulin, one of the most strongly conserved residues in insulins from various species, is substituted with the strongly fluorescent tryptophan residue. [19-Tryptophan-A]insulin displays 4.1±1.9% of the potency of natural insulin in binding to the insulin receptor from rat liver plasma membranes, 5.0±2.3% in stimulating lipogenesis in rat adipocytes, and 75.7±4% of the potency of insulin in radioimmunoassay. In connection with our previous work, these data indicate that an aromatic side chain at position A19 of insulin seems necessary but not sufficient for high biological activity. We further conclude that in regard to the immunogenic determinants of insulin, tryptophan in position A19 is an essentially neutral substitution for tyrosine in that position, in sharp contrast to the situation with regard to biological activity.
1573-4943
15734943
Springer
shingle_catch_all_3 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
Abstract As part of our aim to study the conformation of insulin in solution by time-resolved fluorescence spectroscopy, we have synthesized the analogue [19-Tryptophan-A]insulin. In this compound, the tyrosine residue at position 19 of the A-chain of insulin, one of the most strongly conserved residues in insulins from various species, is substituted with the strongly fluorescent tryptophan residue. [19-Tryptophan-A]insulin displays 4.1±1.9% of the potency of natural insulin in binding to the insulin receptor from rat liver plasma membranes, 5.0±2.3% in stimulating lipogenesis in rat adipocytes, and 75.7±4% of the potency of insulin in radioimmunoassay. In connection with our previous work, these data indicate that an aromatic side chain at position A19 of insulin seems necessary but not sufficient for high biological activity. We further conclude that in regard to the immunogenic determinants of insulin, tryptophan in position A19 is an essentially neutral substitution for tyrosine in that position, in sharp contrast to the situation with regard to biological activity.
1573-4943
15734943
Springer
shingle_catch_all_4 Ohta, Noriya
Burke, G. Thompson
Katsoyannis, Panayotis G.
Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
insulin analogue
peptide synthesis
receptor binding assay
radioimmunoassay
lipogenesis assay
Abstract As part of our aim to study the conformation of insulin in solution by time-resolved fluorescence spectroscopy, we have synthesized the analogue [19-Tryptophan-A]insulin. In this compound, the tyrosine residue at position 19 of the A-chain of insulin, one of the most strongly conserved residues in insulins from various species, is substituted with the strongly fluorescent tryptophan residue. [19-Tryptophan-A]insulin displays 4.1±1.9% of the potency of natural insulin in binding to the insulin receptor from rat liver plasma membranes, 5.0±2.3% in stimulating lipogenesis in rat adipocytes, and 75.7±4% of the potency of insulin in radioimmunoassay. In connection with our previous work, these data indicate that an aromatic side chain at position A19 of insulin seems necessary but not sufficient for high biological activity. We further conclude that in regard to the immunogenic determinants of insulin, tryptophan in position A19 is an essentially neutral substitution for tyrosine in that position, in sharp contrast to the situation with regard to biological activity.
1573-4943
15734943
Springer
shingle_title_1 Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
shingle_title_2 Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
shingle_title_3 Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
shingle_title_4 Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:57:29.779Z
titel Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
titel_suche Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-Tryptophan-A]insulin
topic V
uid nat_lic_papers_NLM197815375